Lv7
5000 积分 2021-06-04 加入
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
15天前
已完结
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
1个月前
已完结
Muscle invasive bladder cancer: where is the field headed?
1个月前
已完结
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
1个月前
已完结
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance
2个月前
已完结
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings
3个月前
已完结
Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval
3个月前
已完结
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
3个月前
已完结
A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer
4个月前
已完结
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
4个月前
已完结
皖公网安备34019202002308
